1. Home
  2. ZYME vs ATHM Comparison

ZYME vs ATHM Comparison

Compare ZYME & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$24.96

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

ATHM

Autohome Inc.

HOLD

Current Price

$16.40

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
ATHM
Founded
2003
2008
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
ZYME
ATHM
Price
$24.96
$16.40
Analyst Decision
Strong Buy
Hold
Analyst Count
11
1
Target Price
$38.90
$28.00
AVG Volume (30 Days)
548.3K
494.3K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
9.83%
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
$105,965,000.00
N/A
Revenue This Year
$183.10
N/A
Revenue Next Year
N/A
$4.77
P/E Ratio
N/A
$12.13
Revenue Growth
38.87
N/A
52 Week Low
$11.02
$16.06
52 Week High
$29.75
$29.92

Technical Indicators

Market Signals
Indicator
ZYME
ATHM
Relative Strength Index (RSI) 45.79 29.83
Support Level $24.79 N/A
Resistance Level $27.54 $19.50
Average True Range (ATR) 1.23 0.60
MACD 0.02 -0.21
Stochastic Oscillator 34.35 9.48

Price Performance

Historical Comparison
ZYME
ATHM

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.

Share on Social Networks: